Validating Liver Stiffness Measurement as a Prognostic Tool in Primary Sclerosing Cholangitis: Insights from the Prospective FICUS Cohort
Highlight
• Liver stiffness measurement (LSM) by Fibroscan® robustly predicts transplant-free survival in PSC.
• Stratification into Baveno-VII classes (<10, 10–<15, ≥15 kPa) correlates strongly with outcome.
• Dynamic LSM changes over time independently add prognostic value beyond baseline measures.
• Incremental LSM progression corresponds to a significant increase in risk of death or transplantation.
Study Background
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
